Clorox (NYSE:CLX) Receives “Neutral” Rating from DA Davidson

DA Davidson reissued their neutral rating on shares of Clorox (NYSE:CLXFree Report) in a research report released on Wednesday morning, Benzinga reports. DA Davidson currently has a $162.00 price target on the stock.

A number of other equities analysts have also issued reports on the company. UBS Group increased their target price on Clorox from $145.00 to $170.00 and gave the company a neutral rating in a research note on Friday, February 2nd. The Goldman Sachs Group began coverage on shares of Clorox in a research note on Friday, March 1st. They set a sell rating and a $140.00 price objective on the stock. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $145.00 to $152.00 and gave the stock a neutral rating in a research report on Thursday, January 18th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $155.00 to $151.00 and set a hold rating on the stock in a research report on Wednesday. Finally, Morgan Stanley restated an equal weight rating and set a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of Hold and a consensus target price of $148.63.

Check Out Our Latest Stock Report on CLX

Clorox Price Performance

Shares of CLX stock opened at $143.58 on Wednesday. The firm has a fifty day simple moving average of $149.99 and a 200-day simple moving average of $141.79. The company has a market capitalization of $17.82 billion, a PE ratio of 227.90, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43. Clorox has a twelve month low of $114.68 and a twelve month high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the company posted $0.98 EPS. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. Equities research analysts anticipate that Clorox will post 5.52 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.34%. Clorox’s dividend payout ratio is presently 761.90%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Tyler Stone Wealth Management acquired a new position in shares of Clorox during the second quarter worth approximately $25,000. O Dell Group LLC bought a new stake in Clorox during the 4th quarter valued at $28,000. Fortitude Family Office LLC acquired a new position in Clorox during the 4th quarter worth $29,000. Northwest Financial Advisors bought a new position in shares of Clorox in the fourth quarter worth $29,000. Finally, Core Wealth Advisors Inc. acquired a new position in shares of Clorox during the fourth quarter valued at $29,000. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.